BusinessaTyr Pharma Provides Mechanistic Update on Resokine Pathway at American Academy of Immunology Annual MeetingBy Nasdaq OMXMay 2, 2018, 12:01 PM UTC
BusinessFluidigm Introduces High-Parameter Maxpar Immune Monitoring Panel for Translational and Clinical ResearchBy Nasdaq OMXApr 13, 2018, 8:10 PM UTC
BusinessTodos Medical reports on results of clinical trials for its blood test for breast cancer screening (TM - B1) conducted at Kaplan Hospital in Rehovot, IsraelBy Nasdaq OMXMar 22, 2018, 12:00 PM UTC
BusinessTodos Medical initiates clinical trial of its blood test for breast cancer in Kaplan Hospital, Rehovot, Israel for subjects undergoing breast cancer screeningBy Nasdaq OMXMar 5, 2018, 1:02 PM UTC
BusinessThe asthma & allergy friendly® Certification Program Showcases Its Certified Products and Services to Thousands of Allergist, Immunologists, and Healthcare Professionals from Around the WorldBy Nasdaq OMXMar 2, 2018, 1:00 PM UTC
BusinessMr. David Ben Naim, CPA, MBA Joins Todos Medical as Chief Financial OfficerBy Nasdaq OMXFeb 6, 2018, 1:00 PM UTC
BusinessNew Study Identifies Successful Approaches to Antimicrobial Stewardship Programs in U.S. HospitalsBy Nasdaq OMXJan 25, 2018, 6:00 PM UTC
BusinessaTyr Pharma to Present at the 36th Annual J.P. Morgan Healthcare ConferenceBy Nasdaq OMXJan 4, 2018, 1:03 PM UTC
